Shares of Canopy Growth Corp (NYSE:CGC) have been assigned a consensus rating of “Hold” from the nineteen ratings firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $60.19.
A number of research firms have weighed in on CGC. Bank of America set a $225.00 price target on shares of Tesla and gave the stock a “sell” rating in a research note on Wednesday, July 3rd. Consumer Edge began coverage on shares of Canopy Growth in a research note on Friday, June 28th. They set an “equal weight” rating on the stock. Alliance Global Partners set a C$75.00 price target on shares of Canopy Growth and gave the stock a “buy” rating in a research note on Monday, May 13th. Desjardins reiterated a “buy” rating on shares of Fiera Capital in a research note on Thursday, July 4th. Finally, Piper Jaffray Companies set a $92.00 price target on shares of Wintrust Financial and gave the stock a “buy” rating in a research note on Monday.
Shares of Canopy Growth stock traded down $2.88 during midday trading on Wednesday, hitting $34.21. The company had a trading volume of 14,116,477 shares, compared to its average volume of 7,068,426. The company’s 50 day moving average price is $41.27. The company has a market cap of $12.83 billion, a PE ratio of -21.52 and a beta of 3.65. The company has a current ratio of 12.32, a quick ratio of 11.49 and a debt-to-equity ratio of 0.12. Canopy Growth has a 1-year low of $24.21 and a 1-year high of $59.25.
Several hedge funds and other institutional investors have recently modified their holdings of CGC. Russell Investments Group Ltd. lifted its holdings in shares of Canopy Growth by 57.3% during the third quarter. Russell Investments Group Ltd. now owns 13,676 shares of the marijuana producer’s stock valued at $657,000 after acquiring an additional 4,982 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Canopy Growth during the third quarter valued at $246,000. Baird Financial Group Inc. bought a new position in shares of Canopy Growth during the third quarter valued at $264,000. Blair William & Co. IL bought a new position in shares of Canopy Growth during the third quarter valued at $294,000. Finally, Tower Research Capital LLC TRC bought a new position in shares of Canopy Growth during the third quarter valued at $239,000. 8.05% of the stock is owned by institutional investors.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Further Reading: The mechanics of the bid-ask spread in trading
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.